Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischemic nephropathy: where are we now?

Stephen C Textor1

  • 1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA. textor.stephen@mayo.edu

Journal of the American Society of Nephrology : JASN
|July 31, 2004
PubMed
Summary

Atherosclerotic renal artery stenosis, linked to aging and microvascular issues, challenges kidney function preservation. Understanding pathophysiology and revascularization risks is crucial for selecting patients who will benefit from intervention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renovascular Disease and Mitochondrial Dysfunction in Human Mesenchymal Stem Cells.

Journal of the American Society of Nephrology : JASN·2024
Same author

Altered immune cell phenotypes within chronically ischemic human kidneys distal to occlusive renal artery disease.

American journal of physiology. Renal physiology·2023
Same author

Effect of Hypoxia Preconditioning on the Regenerative Capacity of Adipose Tissue Derived Mesenchymal Stem Cells in a Model of Renal Artery Stenosis.

Stem cells (Dayton, Ohio)·2022
Same author

Renal denervation in the antihypertensive arsenal - knowns and known unknowns.

Journal of hypertension·2022
Same author

Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association.

Hypertension (Dallas, Tex. : 1979)·2022
Same author

Microvascular remodeling and altered angiogenic signaling in human kidneys distal to occlusive atherosclerotic renal artery stenosis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2022

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Vascular Surgery

Background:

  • Renal artery stenosis (RAS) is a significant cause of kidney function decline, particularly in aging populations.
  • RAS is associated with microvascular diseases like nephrosclerosis and diabetic nephropathy, increasing cardiovascular risks.
  • Medical therapies, including renin-angiotensin system blockers, improve blood pressure control but may not prevent disease progression.

Purpose of the Study:

  • To explore the pathophysiology of ischemic nephropathy due to atherosclerotic renal artery stenosis.
  • To evaluate the outcomes of revascularization in patients with impaired kidney function.
  • To identify patient selection criteria for vascular intervention to prevent further kidney function loss.

Main Methods:

  • Review of recent studies on atherosclerotic renal artery stenosis and its impact on kidney function.
  • Analysis of outcomes following revascularization procedures in patients with varying degrees of renal impairment.
  • Examination of the interplay between oxidative stress, endothelial dysfunction, and fibrogenic cytokines in experimental models.

Main Results:

  • While 25-30% of patients may recover glomerular filtration after revascularization, many show no improvement, and 19-25% experience further kidney function loss.
  • Progressive renovascular disease can lead to refractory hypertension, heart failure, and renal failure.
  • Atheroemboli are a noted complication of revascularization, contributing to kidney function decline.

Conclusions:

  • Understanding the pathophysiology of ischemic nephropathy is vital for managing RAS.
  • Careful patient selection is necessary to maximize benefits and minimize risks associated with revascularization.
  • Further research is needed on critical disease identification, fibrogenesis regulation, and interactions with other atherosclerotic processes.

Related Experiment Videos